Thus, the DII may be a potential clue to reduce the risk of ER+/PR+ tumors regardless of menopausal status in Korean women, and the DII might be more intensively associated with breast cancer risk in postmenopausal women. The gene discussed is ESR1; the disease is breast carcinoma.